FACIT operates as a commercialization venture firm focused on oncology innovation in Ontario. It identifies, accesses, and supports technologies with high potential to address unmet oncology needs by applying venture capital and market-driven investing principles. FACIT's model brings together entrepreneurial scientists, partner institutions, and other stakeholders to commercialize life science innovations. They actively partner with companies, providing capital, experienced executive management, and connections to their industry and investor network to help them grow and scale in Ontario. This "Ontario First" strategy aims to ensure that investments in cancer research have the best opportunity to impact patient care.
Bevorzugte Reifephase für die erste Finanzierung.
Oncology, Therapeutics, Diagnostics, Medical Technologies, Imaging, Technology Platforms
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...